New T-cell test to determine past exposure to SARS-CoV-2 is cool science but not a game changer. It may help answer why some become long-haulers after infection while others do not and it is a starting point for discovery and treatment research.

Dr. Barry Dworkin

Medical Mythbusting Commentary for March 10, 2021

[display_podcast]

Source:
FDA authorizes new T-cell test that could be game changer for COVID-19 long haulers

Related posts:

  1. AstraZeneca is soon to publish results from its pre-exposure prophylaxis trial about anti-Covid antibodies given IM to people with comorbid states that reduce the immune response from vaccines. Reduced severe symptomatic risk (relative) by 77%.
  2. Genes research offers cancer treatment hope
  3. Gene discovery opens new avenue to understand what causes asthma
  4. The development of mRNA vaccine technology has the potential to expand to treat and prevent other diseases akin to the technological spinoffs seen with the Apollo space program.